KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Capital Employed (2016 - 2025)

TherapeuticsMD (TXMD) has disclosed Return on Capital Employed for 13 consecutive years, with 0.06% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed rose 13.0% year-over-year to 0.06%, compared with a TTM value of 0.06% through Sep 2025, up 13.0%, and an annual FY2024 reading of 0.13%, up 1.0% over the prior year.
  • Return on Capital Employed was 0.06% for Q3 2025 at TherapeuticsMD, up from 0.07% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 1.98% in Q2 2022 and bottomed at 1.12% in Q3 2021.
  • Average Return on Capital Employed over 5 years is 0.09%, with a median of 0.1% recorded in 2025.
  • The sharpest move saw Return on Capital Employed skyrocketed 281bps in 2022, then tumbled -130bps in 2024.
  • Year by year, Return on Capital Employed stood at 1.26% in 2021, then tumbled by -99bps to 0.02% in 2022, then tumbled by -1268bps to 0.21% in 2023, then soared by 34bps to 0.14% in 2024, then soared by 55bps to 0.06% in 2025.
  • Business Quant data shows Return on Capital Employed for TXMD at 0.06% in Q3 2025, 0.07% in Q2 2025, and 0.13% in Q1 2025.